SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA conducts inspection at Alembic Pharmaceuticals’ API Facility at Panelav

24 Apr 2018 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals’ API Facility located at Panelav from April 16, 2018 to April 23, 2018. This was a scheduled inspection and at the end of the inspection, there were zero 483s.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company now has a total of 71 ANDA approvals (63 final approvals and 8 tentative approvals) from USFDA.


Alembic Pharma Share Price

767.85 4.30 (0.56%)
22-Apr-2026 10:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.45
Dr. Reddys Lab 1215.40
Cipla 1226.30
Zydus Lifesciences 928.40
Lupin 2300.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×